Author
Listed:
- Maikel L. Colli
(Université Libre de Bruxelles)
- Mireia Ramos-Rodríguez
(University Pompeu Fabra
Germans Trias i Pujol University Hospital and Research Institute)
- Ernesto S. Nakayasu
(Pacific Northwest National Laboratory)
- Maria I. Alvelos
(Université Libre de Bruxelles)
- Miguel Lopes
(Université Libre de Bruxelles)
- Jessica L. E. Hill
(University of Exeter Medical School)
- Jean-Valery Turatsinze
(Université Libre de Bruxelles)
- Alexandra Coomans de Brachène
(Université Libre de Bruxelles)
- Mark A. Russell
(University of Exeter Medical School)
- Helena Raurell-Vila
(University Pompeu Fabra
Germans Trias i Pujol University Hospital and Research Institute)
- Angela Castela
(Université Libre de Bruxelles)
- Jonàs Juan-Mateu
(Université Libre de Bruxelles)
- Bobbie-Jo M. Webb-Robertson
(Pacific Northwest National Laboratory)
- Lars Krogvold
(Oslo University Hospital)
- Knut Dahl-Jorgensen
(Oslo University Hospital)
- Lorella Marselli
(Islet Cell Laboratory, University of Pisa)
- Piero Marchetti
(Islet Cell Laboratory, University of Pisa)
- Sarah J. Richardson
(University of Exeter Medical School)
- Noel G. Morgan
(University of Exeter Medical School)
- Thomas O. Metz
(Pacific Northwest National Laboratory)
- Lorenzo Pasquali
(University Pompeu Fabra
Germans Trias i Pujol University Hospital and Research Institute
Josep Carreras Leukaemia Research Institute (IJC))
- Décio L. Eizirik
(Université Libre de Bruxelles
Université Libre de Bruxelles
Indiana Biosciences Research Institute)
Abstract
Interferon-α (IFNα), a type I interferon, is expressed in the islets of type 1 diabetic individuals, and its expression and signaling are regulated by T1D genetic risk variants and viral infections associated with T1D. We presently characterize human beta cell responses to IFNα by combining ATAC-seq, RNA-seq and proteomics assays. The initial response to IFNα is characterized by chromatin remodeling, followed by changes in transcriptional and translational regulation. IFNα induces changes in alternative splicing (AS) and first exon usage, increasing the diversity of transcripts expressed by the beta cells. This, combined with changes observed on protein modification/degradation, ER stress and MHC class I, may expand antigens presented by beta cells to the immune system. Beta cells also up-regulate the checkpoint proteins PDL1 and HLA-E that may exert a protective role against the autoimmune assault. Data mining of the present multi-omics analysis identifies two compound classes that antagonize IFNα effects on human beta cells.
Suggested Citation
Maikel L. Colli & Mireia Ramos-Rodríguez & Ernesto S. Nakayasu & Maria I. Alvelos & Miguel Lopes & Jessica L. E. Hill & Jean-Valery Turatsinze & Alexandra Coomans de Brachène & Mark A. Russell & Helen, 2020.
"An integrated multi-omics approach identifies the landscape of interferon-α-mediated responses of human pancreatic beta cells,"
Nature Communications, Nature, vol. 11(1), pages 1-17, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-16327-0
DOI: 10.1038/s41467-020-16327-0
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Marlie M. Maestas & Matthew Ishahak & Punn Augsornworawat & Daniel A. Veronese-Paniagua & Kristina G. Maxwell & Leonardo Velazco-Cruz & Erica Marquez & Jiameng Sun & Mira Shunkarova & Sarah E. Gale & , 2024.
"Identification of unique cell type responses in pancreatic islets to stress,"
Nature Communications, Nature, vol. 15(1), pages 1-17, December.
- Guanlan Xu & Tiffany D. Grimes & Truman B. Grayson & Junqin Chen & Lance A. Thielen & Hubert M. Tse & Peng Li & Matt Kanke & Tai-Tu Lin & Athena A. Schepmoes & Adam C. Swensen & Vladislav A. Petyuk & , 2022.
"Exploratory study reveals far reaching systemic and cellular effects of verapamil treatment in subjects with type 1 diabetes,"
Nature Communications, Nature, vol. 13(1), pages 1-9, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-16327-0. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.